Peptide LexiconAll compounds

BNP and NT-proBNP: One Hormone, Two Tests, and Why They Disagree

A 108-residue prohormone splits into two fragments — NT-proBNP at 76 residues and BNP at 32. One is cleared by an enzyme, the other is not, which is why a common heart-failure drug pushes the two tests in opposite directions.

A human hormone, not a sold compoundMeasured as a clinical laboratory testNot a research peptide and not available for purchase

Caroline S · Published 2026-09-19

Length

BNP-32 is 32 amino acids. NT-proBNP is 76. They are the two halves of one 108-residue prohormone.

Sequence

The gene NPPB encodes a 134-residue preprohormone (UniProt P16860). Residues 1–26 are a signal peptide; residues 27–134 are proBNP, 108 residues long. Cleavage splits proBNP into NT-proBNP (residues 27–102, 76 residues) and BNP-32 (residues 103–134).

Origin

Made by the heart's ventricular muscle in response to wall stretch. It is a human hormone, present in everyone; the laboratory tests measure how much of it is circulating.

Last reviewed

2026-09-19

What is it good for?

Nothing is sold under these names and nothing is taken. Both are measured, not administered: they are blood tests used in the assessment of heart failure. This entry exists because readers reach the word peptide through them and because they are the clearest example in this library of one molecule producing two different numbers.

Illustration: Three clear glass fragments on a white lab bench.
Illustration

Most entries in this library describe something sold in a vial. This one does not. BNP is a hormone the human heart makes, and it appears here for the same reason C-peptide does: the word peptide is in its name, it turns up on ordinary blood test reports, and a reader who arrives that way deserves to find out in one sentence that it is unrelated to the compounds most of these pages describe.

It also happens to be the clearest illustration in the library of something worth understanding: one molecule can produce two different laboratory numbers, and those numbers can move in opposite directions.

The arithmetic of one hormone becoming two tests

The gene NPPB encodes a 134-residue preprohormone (UniProt P16860). The first 26 residues are a signal peptide, removed as the molecule is processed. What remains is proBNP, 108 residues long.

ProBNP is then cut once. The cut produces:

  • NT-proBNP — residues 27 to 102 of the precursor, 76 residues. The N-terminal leftover. No established hormonal activity of its own.
  • BNP-32 — residues 103 to 134, 32 residues. The active hormone.

The arithmetic closes exactly: 76 + 32 = 108. Anyone can check it against the UniProt record; that is the whole relationship between the two tests.

The heart's ventricular muscle makes this in response to stretch of the chamber wall. Both fragments reach the bloodstream, and both can be measured — which is why a single hormone ended up with two assays rather than one.

"BNP" is a family, not a molecule

The UniProt record for the same protein lists nineteen distinct named BNP-derived peptide forms circulating in human blood. Alongside full-length BNP-32 there are BNP(1-30), BNP(1-29), BNP(1-28), BNP(2-31), BNP(3-32), BNP(3-30), BNP(3-29), BNP(4-31), BNP(4-30), BNP(4-29), BNP(4-27), BNP(5-32), BNP(5-31), BNP(5-29) and BNP-29, among others — the same chain shortened from one end or the other.

This is not a curiosity. What a given assay reports depends on which of those forms its antibodies bind, which is a large part of why results produced by different manufacturers' assays are not interchangeable. A number on a report is a measurement made by a particular instrument, not a count of molecules.

The finding: a drug label that states the two tests disagree

The most useful documented example of why the distinction matters is printed on a prescribing information sheet.

Entresto combines sacubitril, a neprilysin inhibitor, with valsartan. Neprilysin is the enzyme that degrades natriuretic peptides; inhibiting it is the point of the drug. BNP is one of that enzyme's substrates. NT-proBNP is not.

The label puts the consequence in a single sentence. In the PARADIGM-HF trial, it records, the drug decreased plasma NT-proBNP (not a neprilysin substrate) and increased plasma BNP (a neprilysin substrate) compared with enalapril.

One drug. One hormone. Two tests that move in opposite directions — and the manufacturer says so in its own clinical pharmacology section. The same label reports NT-proBNP falling by 17% in PARAMOUNT and by 24% at week 16 in PARAGON-HF.

The scale of it

Two figures put this entry in proportion against the rest of the library. On 2026-09-19, PubMed held 32,314 records for B-type natriuretic peptide and 15,865 for NT-proBNP. The FDA's 510(k) database returned 14 clearances for devices named for natriuretic peptide and 12 for NT-proBNP.

For comparison, the largest literature attached to any compound sold as a research peptide in this library is BPC-157 at 230 PubMed records, none of them a clinical trial. The contrast is the point: this is what a molecule with an established clinical role looks like in the public record, and it does not resemble the compounds most of these entries describe.

Where it stands

Nothing here is sold and nothing is taken. There is no research-chemical market for BNP or NT-proBNP, no vial, and no dose — only assays, and a large clinical literature about how to read them.

This entry deliberately carries no reference ranges and no interpretation of any result. Those numbers depend on the assay used and on the person, and they are read alongside symptoms, examination and imaging by the clinician who ordered the test. If you are holding a result, that clinician is the person to ask.

Related entries: C-peptide, the other clinical lab marker in this library that people reach through the word peptide; what a peptide actually is; and the peptide bond, if the 108-into-76-plus-32 arithmetic above is the part you want to check yourself.

What the research shows

This is a compound anyone can buy or use

It is an endogenous human hormone measured by clinical laboratory assays; no research-chemical market exists for it

The two tests measure the same molecule

They measure the two separate fragments produced when one 108-residue prohormone is cleaved — 76 residues and 32 residues

The two tests move together

The Entresto (sacubitril/valsartan) label states that in PARADIGM-HF the drug decreased plasma NT-proBNP and increased plasma BNP

'BNP' names a single circulating molecule

UniProt P16860 records nineteen distinct named BNP-derived peptide forms, from BNP(4-27) to the full BNP-32

These assays are established clinical tests

The FDA 510(k) database returned 14 clearances for devices named for natriuretic peptide and 12 for NT-proBNP on 2026-09-19

Bars show how much of the evidence is in humans, not how well anything works.

Frequently asked questions

Is BNP a peptide?

Yes, in the plain chemical sense: BNP-32 is a chain of 32 amino acids joined by peptide bonds. It is not a peptide in the sense most of this library uses the word, because nothing is sold under the name and nobody takes it. It is a hormone your own heart makes, and the laboratory measures how much of it is circulating.

What is the difference between BNP and NT-proBNP?

They are the two halves of the same molecule. The heart makes a 108-residue prohormone called proBNP and then cuts it in two. The active 32-residue piece is BNP; the inactive 76-residue leftover is NT-proBNP. Both end up in the blood and both can be measured, which is why two tests exist for what began as one hormone.

Why would two tests of the same hormone give different answers?

Because only one of the two fragments is broken down by the enzyme neprilysin. BNP is a substrate for it; NT-proBNP is not. Anything that changes neprilysin activity therefore changes one number without changing the other in the same direction. The clearest documented case is on a drug label: Entresto contains a neprilysin inhibitor, and its prescribing information states that in the PARADIGM-HF trial the drug decreased NT-proBNP and increased BNP.

Does 'BNP' mean one molecule?

Not exactly. UniProt lists nineteen distinct named BNP-derived forms found in human blood — the full 32-residue peptide plus shortened versions such as BNP(1-30), BNP(3-32) and BNP(4-27). What a given assay reports depends on which of those forms its antibodies recognise, which is one reason results from different assays are not interchangeable.

What does a BNP result mean for me?

That is not a question this library can answer, and it is not a question a reference range answers either. These tests are interpreted alongside symptoms, examination, imaging and other results by the clinician who ordered them — age, kidney function, body weight, atrial fibrillation and several medicines all shift the numbers. If you are holding a result, the person to ask is the one who ordered it.

Why is this entry in a peptide library?

Because people arrive at the word peptide through it. 'B-type natriuretic peptide' contains the word, appears on ordinary blood test reports, and has nothing in common with the compounds most of this library describes. Like [C-peptide](/c-peptide), it is here so that a reader who lands on the word by way of a lab report finds out quickly that they are in the wrong aisle.